Hyderabad, May 19 -- In a landmark development in the field of neurotechnology, the United Arab Emirates (UAE) is set to host the first clinical trial of Neuralink's wireless brain chip outside the United States (US).

The neurotechnology company, founded by Elon Musk in 2016, has partnered with the Department of Health - Abu Dhabi and Cleveland Clinic Abu Dhabi for the study, titled UAE-PRIME.

The trial will assess Neuralink's implantable brain-computer interface (BCI), which records neural activity and translates it into digital signals. For individuals with motor and speech impairments, the technology offers a transformative way to interact with their surroundings using thought alone.

The UAE-PRIME trial will focus on people affected...